Skip to content
Screener

Disc Medicine IRON Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Beam Therapeutics logo
Beam TherapeuticsBEAM
-$96.5M+11.3%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$36.98M+11.9%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.97B+46.0%
Enterprise value$2.92B+50.2%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 8:33 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-205192
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Weighted-average common shares outstanding, basic and diluted38,491,43333,324,745
Comprehensive loss:
Net loss$(63,504)$(34,085)
Other comprehensive (loss) income:
Foreign currency translation adjustments(10)14
Unrealized (loss) gain on marketable securities(1,526)232
Total other comprehensive (loss) income(1,536)246
Comprehensive loss$(65,040)$(33,839)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Disc Medicine's comprehensive income (loss), net of tax, attributable to parent?
Disc Medicine (IRON) reported comprehensive income (loss), net of tax, attributable to parent of -$65.04M in Q1 2026.
How has Disc Medicine's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Disc Medicine's comprehensive income (loss), net of tax, attributable to parent decreased by 92.2% year-over-year, from -$33.84M to -$65.04M.
What is the long-term trend for Disc Medicine's comprehensive income (loss), net of tax, attributable to parent?
Over 2 years (2023 to 2025), Disc Medicine's comprehensive income (loss), net of tax, attributable to parent has grown at a 66.4% compound annual growth rate (CAGR), from -$76.43M to -$211.51M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This metric represents the total change in equity during a period resulting from transactions and other events from non-owner sources, including both net income and other comprehensive income items. It provides a more holistic view of financial performance by incorporating unrealized gains or losses that are excluded from traditional net income. Investors use this to assess the broader impact of market conditions and accounting adjustments on the company's overall financial position.

Ask your AI about Disc Medicine's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude